aimintang Bank of America picked up coverage on Home Depot ( HD ) again with a Buy rating and called it the firm's preferred stock within the home improvement sector. Analyst Christopher Nardone and his team think Home Depot ( HD ) can outgrow peers during a benign housing backdrop due to its higher Pro exposure (50% of sales). "Superior strategy and execution have underpinned HD's market share ga...
aimintang Bank of America picked up coverage on Home Depot ( HD ) again with a Buy rating and called it the firm's preferred stock within the home improvement sector. Analyst Christopher Nardone and his team think Home Depot ( HD ) can outgrow peers during a benign housing backdrop due to its higher Pro exposure (50% of sales). "Superior strategy and execution have underpinned HD's market share gains over the last decade, and we believe HD will continue to outperform the overall renovation category, which has favorable tailwinds for the near and long term," highlighted Nardone. Notably, the acquisitions of SRS Distribution and Gypsum Management Supply are expected to accelerate the sales recovery for Home Depot ( HD ) once the housing market improves. In terms of valuation, the stock’s pullback to 19X PE is seen as giving investors a compelling entry point. The firm's price objective of $374 is based on 23X P/E, a slight premium to the long-term average of 20x due to BofA's forecast for a multi-year EPS acceleration. Shares of Home Depot ( HD ) edged 0.2% higher in premarket trading to $313.13. More on Home Depot The Home Depot, Inc. (HD) Presents at J.P. Morgan Retail Round Up Forum 2026 Transcript Stay Away From Home Depot Amid Macroeconomic Headwinds (Rating Downgrade) Lowe's Or Home Depot? Former Still The Better Choice Two Quarters On Tariff refunds: A win for importers, but not so much for consumers Corporate America’s big job cuts in 2026 - What do we know so far?
alexsl Goldman Sachs’ equity positioning gauge is flashing a note of caution as hedge funds cut exposure to megacap stocks ( QQQ ). Goldman’s U.S. equity sentiment indicator rose to 1.7 this week, its highest level since late 2024, though still below previous extremes. The indicator combines nine measures of positioning across retail, institutional and foreign investors, with the latest increase d...
alexsl Goldman Sachs’ equity positioning gauge is flashing a note of caution as hedge funds cut exposure to megacap stocks ( QQQ ). Goldman’s U.S. equity sentiment indicator rose to 1.7 this week, its highest level since late 2024, though still below previous extremes. The indicator combines nine measures of positioning across retail, institutional and foreign investors, with the latest increase driven by passive equity fund inflows and a decline in mutual fund cash balances. Goldman noted that readings above 1.0 signal stretched positioning. Since the global financial crisis, readings between 1.5 and 2.0 have typically preceded below-average one-month S&P 500 ( SPY ) ( IVV ) ( VOO ) returns, averaging -0.4%, although the firm said the signal from elevated readings is not as strong as the one from depressed readings. Goldman Sachs At the same time, hedge funds have been reducing exposure to technology. Goldman’s prime brokerage data showed U.S. equities were net sold for a third straight week and in 10 of the last 11 weeks, driven by both short and long sales in single stocks. Hedge funds also unwound risk in U.S. Info Tech ( XLK ) stocks for a second straight week, with the recent two-week degrossing the largest in the past decade excluding the Jan./Feb. 2021 meme-stock frenzy . The Magnificent 7 group ( AAPL ) ( AMZN ) ( GOOG ) ( GOOGL ) ( META ) ( MSFT ) ( NVDA ) ( TSLA ) also saw reduced risk ahead of a busy megacap earnings stretch. Goldman said the stocks collectively saw degrossing activity and were net sold in four of the five trading sessions last week, with long sales outpacing short covers. The note adds a positioning caveat to the market’s recent strength: sentiment has improved, but some of the largest and most important leadership stocks are seeing hedge funds trim exposure. More on SPDR S&P 500 ETF Trust SPX Realized Skew Inverts As Traders Focus On Right Tail Oil Spikes Rhyme Through Time The 4 Effects Pumping S&P 500 And Tech/AI Earnings Earnings st...
Foryou13 KKR ( KKR ) delivered stronger-than-expected Q1 earnings on Tuesday as fee-related earnings, total operating earnings, and adjusted EPS each grew ~20% Y/Y. Q1 adjusted EPS of $1.39, topping the average analyst estimate of $1.26, rose from $1.12 in Q4 2025 and $1.15 in last year’s Q1. Fee-related earnings of $1.02B, beating the Visible Alpha consensus of $985.3M, increased from $972.0M in ...
Foryou13 KKR ( KKR ) delivered stronger-than-expected Q1 earnings on Tuesday as fee-related earnings, total operating earnings, and adjusted EPS each grew ~20% Y/Y. Q1 adjusted EPS of $1.39, topping the average analyst estimate of $1.26, rose from $1.12 in Q4 2025 and $1.15 in last year’s Q1. Fee-related earnings of $1.02B, beating the Visible Alpha consensus of $985.3M, increased from $972.0M in the previous quarter and $822.6M in the year-ago period. Total operating earnings of $1.33B vs. $1.28B in Q4 and $1.11B in Q1 2025. "Against a volatile backdrop, monetization activity accelerated, and over the past 12 months we’ve invested more capital on behalf of our clients than at any point in our history," said Co-CEOs Joseph Y. Bae and Scott C. Nuttall. KKR ( KKR ) stock rose 0.9% in premarket trading. Assets under management of $758B, vs. the Visible Alpha consensus of $763B, climbed from $744B at the end of Q3. The company raised $28B in the quarter vs. $28B in the prior quarter and invested $22B vs. $32B in Q4. Uncalled commitments, commonly called dry powder, sat at $124.9B vs. $118.4B at Dec. 31, 2025. Gross return by fund type (gross unrealized performance income totaled $10.2B at March 31, 2026): Traditional private equity portfolio: +1% in Q4 vs. +4% in Q4; +10% in the past 12 months. Real assets: Opportunistic real estate portfolio: -1% vs. 0% in Q4; +2% last 12 months. Infrastructure portfolio: +2% in Q1 vs. +2% in the prior quarter; +10% in the last 12 months. Credit: Leveraged credit composite: -1% vs. +1% in the prior quarter; +5% last 12 months. Alternative credit composite: -1% vs. +1% in Q4; +4% last 12 months. Conference call at 10:00 AM ET. More on KKR & Co. KKR Round Two: Poised To Grow Earnings At A Double-Digit Rate KKR: A Compounding Machine Hidden Behind Private Markets Complexity KKR & Co. Inc. (KKR) Shareholder/Analyst Call - Slideshow KKR & Co. Non-GAAP EPS of $1.39 beats by $0.13 KKR bags over $10B financing for AI infrastructure developer l...
IQVIA press release ( IQV ): Q1 Non-GAAP EPS of $2.90 beats by $0.08 . Revenue of $4.15B (+8.4% Y/Y) beats by $50M . Commercial Solutions Revenue of $1,754 million, up 11.6% reported year-over-year R&D Solutions Revenue of $2,397 million, up 6.2% reported year-over-year R&D Solutions contracted backlog of $34.2 billion, R&D Solutions Net New Bookings of $2.5 billion Operating Cash Flow of $618 mil...
IQVIA press release ( IQV ): Q1 Non-GAAP EPS of $2.90 beats by $0.08 . Revenue of $4.15B (+8.4% Y/Y) beats by $50M . Commercial Solutions Revenue of $1,754 million, up 11.6% reported year-over-year R&D Solutions Revenue of $2,397 million, up 6.2% reported year-over-year R&D Solutions contracted backlog of $34.2 billion, R&D Solutions Net New Bookings of $2.5 billion Operating Cash Flow of $618 million; Free Cash Flow of $491 million, up 15% year-over-year, representing 100% of Adjusted Net Income Repurchased $552 million of IQVIA ( IQV ) common stock Reaffirming full-year 2026 guidance for revenue and Adjusted EBITDA; raising full-year 2026 guidance for Adjusted Diluted Earnings per Share to $12.65 - $12.95 (vs. consensus of $12.70) More on IQVIA IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript IQVIA Holdings Inc. (IQV) Presents at Leerink Global Healthcare Conference 2026 Transcript IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder IQVIA Q1 2026 Earnings Preview OpenAI launches GPT-Rosalind, an AI model for life sciences research
uniQure press release ( QURE ): Q1 GAAP EPS of -$0.85 beats by $0.01 . Revenue of $3.56M (+126.8% Y/Y) misses by $1.71M . The increase of $2.0 million is due to an increase in license revenue, compared to the prior period. More on uniQure A Unique Situation For UniQure uniQure: Worst Case Scenario Becomes Reality uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade) uniQure rises a...
uniQure press release ( QURE ): Q1 GAAP EPS of -$0.85 beats by $0.01 . Revenue of $3.56M (+126.8% Y/Y) misses by $1.71M . The increase of $2.0 million is due to an increase in license revenue, compared to the prior period. More on uniQure A Unique Situation For UniQure uniQure: Worst Case Scenario Becomes Reality uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade) uniQure rises after regulatory updates on gene therapy uniQure upgraded at Mizuho on improved outlook for Huntington's asset AMT-130
Sunoco LP press release ( SUN ): Q1 GAAP EPS of $2.85 beats by $1.13 . Revenue of $10.69B (+106.4% Y/Y) beats by $500M . Adjusted EBITDA of $867 million, excluding one-time transaction-related expenses, and Distributable Cash Flow, as adjusted (1) , of $535 million. Increases quarterly distribution by 6.25%. The first quarter of 2026 distribution represents an increase of over 10% versus the first...
Sunoco LP press release ( SUN ): Q1 GAAP EPS of $2.85 beats by $1.13 . Revenue of $10.69B (+106.4% Y/Y) beats by $500M . Adjusted EBITDA of $867 million, excluding one-time transaction-related expenses, and Distributable Cash Flow, as adjusted (1) , of $535 million. Increases quarterly distribution by 6.25%. The first quarter of 2026 distribution represents an increase of over 10% versus the first quarter of 2025. More on Sunoco LP I Own The Gas Pump With 6% Yields And 5% Dividend Growth: Sunoco Sunoco: Set For Distribution Growth Despite IDR Headwinds Sunoco After Earnings: New All-Time Highs Within Reach (Upgrade) Sunoco LP Q1 2026 Earnings Preview Sunoco prices upsized $1.2B senior notes
WEC Energy press release ( WEC ): Q1 GAAP EPS of $2.45 beats by $0.12 . Revenue of $3.43B (+8.9% Y/Y) beats by $10M . The company is reaffirming its 2026 earnings guidance of $5.51 to $5.61 per share vs. $5.60 consensus More on WEC Energy WEC Energy: The Time To Buy Has Now Passed (Rating Downgrade) WEC Energy Group: Earnings Potential Tied To Capital Plan Execution WEC Energy: Keep Warm With Util...
WEC Energy press release ( WEC ): Q1 GAAP EPS of $2.45 beats by $0.12 . Revenue of $3.43B (+8.9% Y/Y) beats by $10M . The company is reaffirming its 2026 earnings guidance of $5.51 to $5.61 per share vs. $5.60 consensus More on WEC Energy WEC Energy: The Time To Buy Has Now Passed (Rating Downgrade) WEC Energy Group: Earnings Potential Tied To Capital Plan Execution WEC Energy: Keep Warm With Utility Dividends WEC Energy Q1 2026 Earnings Preview Quant check: Power stocks in focus as EVs, data center demand drive global electricity surge
Duke Energy press release ( DUK ): Q1 Non-GAAP EPS of $1.93 beats by $0.13 . Revenue of $9.18B (+11.3% Y/Y) beats by $690M . The company is reaffirming its 2026 adjusted EPS guidance of $6.55 to $6.80 vs $6.70 consensus and long-term adjusted EPS growth rate of 5% to 7% through 2030 off the 2025 midpoint of $6.30, with confidence to earn in the top half of the range beginning in 2028. More on Duke...
Duke Energy press release ( DUK ): Q1 Non-GAAP EPS of $1.93 beats by $0.13 . Revenue of $9.18B (+11.3% Y/Y) beats by $690M . The company is reaffirming its 2026 adjusted EPS guidance of $6.55 to $6.80 vs $6.70 consensus and long-term adjusted EPS growth rate of 5% to 7% through 2030 off the 2025 midpoint of $6.30, with confidence to earn in the top half of the range beginning in 2028. More on Duke Energy Duke Energy's Products Give Us A Credit Risk-Free Opportunity Once Again Duke Energy: Surging Treasury Yields Could Spark Volatility For This Utility Duke Energy: Prime Sunbelt Assets Set It Up For AI Tailwinds Duke Energy preview – this utility faces rate-driven volatility Duke Energy gets NRC extension to operate Robinson nuclear plant to 2050
Rockwell Automation press release ( ROK ): Q2 Non-GAAP EPS of $3.30 beats by $0.42 . Revenue of $2.24B (+12.0% Y/Y) beats by $80M . Total ARR up 6% year over year Updates fiscal 2026 reported sales growth and organic sales growth ranges to 5% - 9% Updates fiscal 2026 diluted EPS guidance range to $11.88 - $12.48 and Adjusted EPS guidance range to $12.50 - $13.10 Introduces Enterprise operating pro...
Rockwell Automation press release ( ROK ): Q2 Non-GAAP EPS of $3.30 beats by $0.42 . Revenue of $2.24B (+12.0% Y/Y) beats by $80M . Total ARR up 6% year over year Updates fiscal 2026 reported sales growth and organic sales growth ranges to 5% - 9% Updates fiscal 2026 diluted EPS guidance range to $11.88 - $12.48 and Adjusted EPS guidance range to $12.50 - $13.10 Introduces Enterprise operating profit and Enterprise operating margin performance measures, which include Corporate and other expenses. Fiscal Year 2026 Outlook The table below provides updated fiscal 2026 guidance . Following the April 1, 2026 dissolution of the Sensia joint venture, the sales, earnings, and cash flows of the divested businesses are excluded from second-half guidance. Organic sales growth for the third and fourth quarters will reflect adjustments for comparable prior-year periods. Updated Guidance (1) Prior Guidance (1) Reported sales midpoint ~$8.9B vs. $8.87B consensus ~$8.8B Reported sales growth 5% - 9% 3% - 7% Organic sales growth (2) 5% - 9% 2% - 6% Divestiture ~ (1.5)% ~ 0% Currency translation ~ 1.5% ~ 1% Diluted EPS $11.88 - $12.48 $10.75 - $11.55 Adjusted EPS (2) $12.50 - $13.10 vs. $12.14 consensus $11.40 - $12.20 Click to enlarge More on Rockwell Automation Rockwell Automation: The Premiumization Is Unconvincing In 2026 Rockwell Automation, Inc. (ROK) Presents at Bank of America Global Industrials Conference 2026 Transcript Rockwell Automation, Inc. (ROK) Presents at Bank of America Global Industrials Conference 2026 - Slideshow Rockwell Automation Q2 2026 Earnings Preview Rockwell Automation declares $1.38 dividend
Jeenah Moon/Getty Images News Pfizer ( PFE ) shares were muted even as the company topped Wall Street estimates with its first quarter results and reaffirmed its full-year outlook. The New York-based pharma giant generated adjusted EPS of $0.75 (-18% Y/Y) on revenue of $14.5B, a 5% rise compared to the prior-year quarter, reflecting an operational increase of $304M, or 2%. Pfizer ( PFE ) is workin...
Jeenah Moon/Getty Images News Pfizer ( PFE ) shares were muted even as the company topped Wall Street estimates with its first quarter results and reaffirmed its full-year outlook. The New York-based pharma giant generated adjusted EPS of $0.75 (-18% Y/Y) on revenue of $14.5B, a 5% rise compared to the prior-year quarter, reflecting an operational increase of $304M, or 2%. Pfizer ( PFE ) is working to streamline costs while rebuilding its pipeline to support future growth. However, several key products face increasing pressure, with drugs like Prevnar and Vyndaqel encountering new competition, while demand for COVID-related products continues to decline. Q1 operational growth was driven by higher sales of older medicines, including cancer drug Padcev, blood thinner Eliquis, oncology biosimilars, and migraine treatment Nurtec, though this was partly offset by declining COVID-19 product revenue. The drugmaker reported strong growth in Eliquis sales at around $2.17B (+13% Y/Y, above $1.93B estimates), while COVID-19 medication Paxlovid revenue fell sharply to $186M (-62% Y/Y, below $248.4M estimates), and the Prevnar franchise generated $1.69B (+2% Y/Y, ahead of $1.62B estimates). The company also reaffirmed its 2026 sales guidance of $59.5B to $62.5B, in line with the average analyst expectation of $61.37B . Adjusted diluted EPS is projected to be in the range of $2.80 to $3.00 (vs. consensus of $2.96). Albert Bourla, chairman and CEO of Pfizer, said: “We're off to a strong start in 2026, and it reinforces our confidence that we will successfully navigate this defining period for Pfizer. Our R&D pipeline is advancing on multiple fronts – with positive Phase 3 readouts and encouraging mid-stage results building meaningful momentum – and I'm particularly encouraged by what we're seeing in oncology and obesity, two areas where I believe Pfizer is positioned to lead.” Weighing on the results, Edmund Ingham , Investing Group Leader for Haggerston BioHealth, said, "Pfizer e...
Harley-Davidson press release ( HOG ): Q1 GAAP EPS of $0.22 misses by $0.01 . Revenue of $1.17B (-12.0% Y/Y) beats by $173.38M . North American retail motorcycle sales of 23,803 units, up 14% vs. prior year Global retail motorcycle sales of 33,507 units, up 8% vs. prior year Global dealer inventory levels of new motorcycles ended Q1 '26 down 22% vs. end Q1 '25 HDMC global motorcycle shipments of 3...
Harley-Davidson press release ( HOG ): Q1 GAAP EPS of $0.22 misses by $0.01 . Revenue of $1.17B (-12.0% Y/Y) beats by $173.38M . North American retail motorcycle sales of 23,803 units, up 14% vs. prior year Global retail motorcycle sales of 33,507 units, up 8% vs. prior year Global dealer inventory levels of new motorcycles ended Q1 '26 down 22% vs. end Q1 '25 HDMC global motorcycle shipments of 37,295, down 3% vs. prior year HDMC revenue of $1.1 billion, down 2% vs. prior year HDFS operating income margin of 19.9% Delivered diluted EPS of $0.22 Repurchased $128 million of shares (6.6 million shares) on a discretionary basis Incurred $15 million of costs related to strategic changes, including termination benefits and other restructuring charges For the full year 2026, the Company reaffirms its guidance and continues to expect: HDMC global motorcycle retail sales of 130,000 to 135,000 units HDMC global motorcycle wholesale shipments of 130,000 to 135,000 units HDMC operating income of a $40 million loss to a $10 million profit HDFS operating income of $45 to $60 million LiveWire operating loss of $70 to $80 million Harley-Davidson, Inc. capital investments of $175 to $200 million More on Harley-Davidson Harley-Davidson: Possibly The Next Big Short Squeeze Harley-Davidson: Shares Trading At A Sizeable Discount To Tangible Book Value Harley-Davidson, Inc. (HOG) Discusses HDFS Business Model Update and Strategic Partnerships with KKR and PIMCO - Slideshow Harley-Davidson Q1 2026 Earnings Preview Private credit seeks billions in credit-card debt incurred by consumers
Small-cap stocks delivered some of the most explosive returns in the market over the past month, with the top performers posting gains ranging from 98% to over 157%, a range that reflects both genuine fundamental catalysts and the high-beta volatility that defines the small-cap universe. Leading the list is Viking Acquisition Corp. I ( VACI.WS ) with a 157.63% gain, followed by Atomera ( ATOM ) at...
Small-cap stocks delivered some of the most explosive returns in the market over the past month, with the top performers posting gains ranging from 98% to over 157%, a range that reflects both genuine fundamental catalysts and the high-beta volatility that defines the small-cap universe. Leading the list is Viking Acquisition Corp. I ( VACI.WS ) with a 157.63% gain, followed by Atomera ( ATOM ) at 154.79% and agilon health ( AGL ) at 150.83%, the latter surging on the announcement of healthcare veteran Tim O'Rourke as its new CEO effective May 7, 2026,a leadership change that has reignited investor confidence in a company working to restructure its business model. Bandwidth Inc. ( BAND ) rounded out the top five with a 149.42% gain as its cloud communications platform attracted renewed investor interest. Further down the list, Wolfspeed ( WOLF ) and Xerox ( XRX ) each more than doubled, Wolfspeed surging over 105% in the month as the silicon carbide chipmaker's restructuring narrative gained traction, with its 1-month gain confirmed at approximately 110% by multiple data sources. Inhibrx Biosciences ( INBX ) also crossed the 100% threshold with a verified 1-month gain of roughly 102%, supported by a strong year-over-year performance that has seen the biotech climb nearly 945% over the past year. On the quant side, Rackspace Technology (RXT, 4.48) and Everspin Technologies (MRAM, 4.36) carry Buy ratings, the two names where price momentum and fundamental strength are most clearly aligned across the list. Viking Acquisition Corp. I ( VACI.WS ), 1 month performance percentage: 157.63% Atomera Incorporated ( ATOM ), 1 month performance percentage: 154.79% agilon health, inc. ( AGL ), 1 month performance percentage: 150.84% Bandwidth Inc. ( BAND ), 1 month performance percentage: 149.42% Rackspace Technology, Inc. ( RXT ), 1 month performance percentage: 109.92% Xerox Holdings Corporation ( XRX ), 1 month performance percentage: 106.35% Wolfspeed, Inc. ( WOLF ), 1 month ...